ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003